CORRECTING and REPLACING International Powerhouse: CES 2017 to Draw 50,000 Industry Professionals from Outside the U.S. Representing 150 Countries
Headline of release should read: International Powerhouse: CES 2017 to Draw 50,000 Industry Professionals from Outside the U.S. Representing 150 Countries (instead of International Powerhouse: CES 2017 to Draw 50,000 Industry Professionals from 150 Countries ).
The corrected release reads:
INTERNATIONAL POWERHOUSE: CES 2017 TO DRAW 50,000 INDUSTRY PROFESSIONALS FROM OUTSIDE THE U.S. REPRESENTING 150 COUNTRIES
Eureka Park Marketplace to feature groups of startups from four new countries
CES® 2017 unites the global tech community and will draw 50,000 industry professionals from some 150 countries. The show will bring together exhibiting companies from 57 countries, up nine percent from 2016. In addition, Eureka Park™, the flagship destination for startups at CES 2017, will return for its sixth year. Featuring more than 600 startups from 33 countries, Eureka Park will bring groups of startups from four new countries– the Czech Republic, the Netherlands, New Zealand and Ukraine – to exhibit at CES 2017. Owned and produced by the Consumer Technology Association (CTA)™, CES 2017 will run January 5-8, in Las Vegas, NV.
“The world truly comes to CES,” said Gary Shapiro, president and CEO, CTA. “In some way, shape or form, every major technology company on the planet participates in our show. Global leaders from companies large and small, government, media and more convene at CES to share or experience the latest products and services, meet their next business partner, make deals and/or simply learn about the next wave of tech that is transforming our world for the better.”
Many international attendees travel to CES as part of the International Buyer Program (IBP)-led delegations. CES is a participant in the IBP, sponsored by the U.S. Department of Commerce, International Trade Administration. CES 2017 is expecting more than 100 Official CES Delegations from around the globe.
Reinforcing its global reach, CES 2017 has several areas designed specifically to highlight the international aspects of the show. The Global Technology Marketplace will be home to the nearly 900 international exhibitors at CES 2017. Located in both the Westgate and Sands, Level 1, Hall G, this show floor area will highlight innovative technologies and products from around the world. To help make the most of the CES experience, international attendees have access to an array of services and resources including an International Matchmaking Reception, International Business Centers (IBCs) and on-site interpreters.
“We look forward to participating in CES 2017,” said Art Stavenka, founder and director, Kino-mo, based in London, UK. “We’ve been looking for the best way to launch our new technology that allows images to appear floating in the air – the new holograms for mass market – and expose it to the media. CES provides us a perfect platform for the launch of such a product to the many industry stakeholders we meet there every year.”
“We launched HEASE Robotics because we believe that robotics will change our lives,” said Jade Le Maître, CTO and CO-founder of Lyon, France-based HEASE Robotics. “We built a robot that is fun, simple, and interactive by design. We are looking forward to meeting potential customers and gathering feedback at CES. It’s incredible how startups gain visibility when exhibiting at Eureka Park.”
Note to Editors: The official name of the global technology event is “CES ® .” Please do not use “Consumer Electronics Show” or “International CES” to refer to the event.
CES is the world’s gathering place for all who thrive on the business of consumer technologies. It has served as the proving ground for innovators and breakthrough technologies for 50 years—the global stage where next-generation innovations are introduced to the marketplace. As the largest hands-on event of its kind, CES features all aspects of the industry. Owned and produced by the Consumer Technology Association (CTA)TM, it attracts the world’s business leaders and pioneering thinkers. Check out CES video highlights. Follow CES online at CES.tech and on social.
About Consumer Technology Association:
Consumer Technology Association (CTA)TM, is the trade association representing the $287 billion U.S. consumer technology industry. More than 2,200 companies – 80 percent are small businesses and startups; others are among the world’s best known brands – enjoy the benefits of CTA membership including policy advocacy, market research, technical education, industry promotion, standards development and the fostering of business and strategic relationships. The Consumer Technology Association also owns and produces CES® – the world’s gathering place for all who thrive on the business of consumer technologies. Profits from CES are reinvested into CTA’s industry services.
Reddit AMA with CTA’s Gary
December 14, 2 PM ET
CES Unveiled Las Vegas
January 3, Las Vegas, NV
CES 2017 –
January 5-8, Las Vegas, NV
March 9-12, Snowmass, CO
Digital Patriots Dinner
April 4, National Portrait Gallery
CES on the Hill
April 5, Rayburn Cafeteria
CES Asia 2017
June 7-9, Shanghai, China
June 21-24, Amalfi Coast, Italy
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00 | Pressemelding
Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines
Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10 | Pressemelding
Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest
Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13 | Pressemelding
Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,
Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00 | Pressemelding
Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With
Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41 | Pressemelding
Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00 | Pressemelding
Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i